The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 What Athletes Need to Know About Legality, Safety and Efficacy Training & Conditioning Ozempic Knock Offs Contain Unsafe Substance Banned by FDA, Novo Finds Bloomberg US FDA to convene expert panel to review wider access to some peptides Reuters